Entities / Company
AngioDynamics (United States).
company in California City, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 28
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
AngioDynamics received FDA 510(k) clearance and began international clinical trials in Europe and Hong Kong.Speculative1 report
-
AngioDynamics is classified in the Medical Instruments Industry and has been underperforming the market so far this year.Some support1 report
-
AngioDynamics' Auryon Atherectomy System is currently being tested in clinical trials.Some support2 reports
-
The medical equipment industry in the US is projected to grow at 8.2% per annum, based on a forecast from July 17, 2025.Some support2 reports
-
Prostate cancer is reported as a common condition among men in the United States.Some support1 report
-
AngioDynamics presented at a conference on August 7, 2025, with Jim Clemmer as CEO and Stephen Trowbridge as CFO.Some support1 report
-
AngioDynamics received FDA clearance for its NanoKnife product, which was reported alongside its stock performance relative to the S&P 500.Well supported4 reports
-
James Clemmer made the biggest insider purchase at AngioDynamics on August 27, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Connections
The 1 strongest of 28, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Incepta Pharmaceuticals Mentioned together
Both companies are members of the Medical - Instruments industry sector.
History
Events by the month they beganJune 2026
8 events- AngioDynamics received FDA 510(k) clearance and began international clinical trials in Europe and Hong Kong.
- AngioDynamics is classified in the Medical Instruments Industry and has been underperforming the market so far this year.
- AngioDynamics' Auryon Atherectomy System is currently being tested in clinical trials.
- The medical equipment industry in the US is projected to grow at 8.2% per annum, based on a forecast from July 17, 2025.
- Prostate cancer is reported as a common condition among men in the United States.
- AngioDynamics presented at a conference on August 7, 2025, with Jim Clemmer as CEO and Stephen Trowbridge as CFO.
- AngioDynamics received FDA clearance for its NanoKnife product, which was reported alongside its stock performance relative to the S&P 500.
- James Clemmer made the biggest insider purchase at AngioDynamics on August 27, 2025.